[MBSB] QoQ TTM Result on 30-Sep-2012 [#3]

Stock
[MBSB] MBSB BERHAD
Announcement Date
05-Nov-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Sep-2012 [#3]
Profit Trend
QoQ- -1.45%
YoY- 36.34%
Quarter Report
Latest QR
Upcoming QR
MBSB's Result
MBSB's Financial Summary
View:
Show?
TTM Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 2,184,978 2,015,156 1,831,560 1,691,177 1,510,575 1,353,818 1,269,438 43.67%
PBT 907,827 782,867 656,227 511,678 464,402 447,706 428,262 65.09%
Tax -302,995 -249,487 -209,576 -164,806 -112,429 -111,139 -102,830 105.66%
NP 604,832 533,380 446,651 346,872 351,973 336,567 325,432 51.22%
-
NP to SH 604,832 533,380 446,651 346,872 351,973 336,567 325,432 51.22%
-
Tax Rate 33.38% 31.87% 31.94% 32.21% 24.21% 24.82% 24.01% -
Total Cost 1,580,146 1,481,776 1,384,909 1,344,305 1,158,602 1,017,251 944,006 41.02%
-
Net Worth 1,932,549 1,606,312 1,466,174 1,335,550 1,244,125 1,215,061 933,441 62.51%
Dividend
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Div 328,084 382,817 382,817 54,732 125,006 98,166 98,166 123.70%
Div Payout % 54.24% 71.77% 85.71% 15.78% 35.52% 29.17% 30.16% -
Equity
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Net Worth 1,932,549 1,606,312 1,466,174 1,335,550 1,244,125 1,215,061 933,441 62.51%
NOSH 1,688,701 1,270,214 1,215,129 1,215,905 1,216,272 1,216,156 1,003,916 41.48%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin 27.68% 26.47% 24.39% 20.51% 23.30% 24.86% 25.64% -
ROE 31.30% 33.21% 30.46% 25.97% 28.29% 27.70% 34.86% -
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
RPS 129.39 158.65 150.73 139.09 124.20 111.32 126.45 1.54%
EPS 35.82 41.99 36.76 28.53 28.94 27.67 32.42 6.88%
DPS 19.43 30.14 31.50 4.50 10.28 8.07 9.78 58.10%
NAPS 1.1444 1.2646 1.2066 1.0984 1.0229 0.9991 0.9298 14.86%
Adjusted Per Share Value based on latest NOSH - 1,215,905
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
RPS 26.49 24.43 22.20 20.50 18.31 16.41 15.39 43.67%
EPS 7.33 6.47 5.41 4.21 4.27 4.08 3.95 51.06%
DPS 3.98 4.64 4.64 0.66 1.52 1.19 1.19 123.80%
NAPS 0.2343 0.1947 0.1777 0.1619 0.1508 0.1473 0.1132 62.48%
Price Multiplier on Financial Quarter End Date
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Date 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 -
Price 3.07 2.74 2.26 2.41 2.28 2.18 1.88 -
P/RPS 2.37 1.73 1.50 1.73 1.84 1.96 1.49 36.30%
P/EPS 8.57 6.53 6.15 8.45 7.88 7.88 5.80 29.75%
EY 11.67 15.33 16.26 11.84 12.69 12.69 17.24 -22.92%
DY 6.33 11.00 13.94 1.87 4.51 3.70 5.20 14.02%
P/NAPS 2.68 2.17 1.87 2.19 2.23 2.18 2.02 20.76%
Price Multiplier on Announcement Date
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Date 31/07/13 03/05/13 31/01/13 05/11/12 30/08/12 11/05/12 02/02/12 -
Price 3.10 2.80 2.26 2.28 2.30 2.26 2.23 -
P/RPS 2.40 1.76 1.50 1.64 1.85 2.03 1.76 22.99%
P/EPS 8.66 6.67 6.15 7.99 7.95 8.17 6.88 16.59%
EY 11.55 15.00 16.26 12.51 12.58 12.25 14.54 -14.24%
DY 6.27 10.76 13.94 1.97 4.47 3.57 4.38 27.04%
P/NAPS 2.71 2.21 1.87 2.08 2.25 2.26 2.40 8.44%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment